The Asian Scientist 100
Lu Ke
Institution
Chinese Academy of Sciences
Country
China
Field
Materials Sciences
Lu is the winner of the 2020 Future Science Prize (Physical Science Prize) for discovering and synthesizing a superior nanotwinned structure and gradient nanostructure.
(Photo: Future Science Prize)
AWARDS
- Future Science Prize 2020
Related articles
Asia’s Rising Scientists: Ernest Chua
Wielding his expertise in mechanical engineering, Ernest Chua aims to develop innovations that can satisfy basic human needs without harming the environment.
Data Is The New Oil And Electricity
As artificial intelligence becomes increasingly pervasive in our daily lives, policies and laws need to be examined for the protection of and access to the data driving it, experts said.
Engendering Trust In An AI World
Regulators play a balancing act between protecting individuals and enabling business innovation, said speakers at a conference on AI and commercial law organised by SMU.
Speak Math, Not Code
Writing algorithms in mathematics rather than code is not only more elegant but also more efficient, says 2013 Turing Award winner Leslie Lamport.
The GDP Fudge: China Edition
By linking GDP growth to promotions, the Chinese government has inadvertently created incentives for provincial officials to report inaccurate financial data, a study says.
7 Best Practices From Singapore’s Pandemic Preparedness Playbook
Amid the COVID-19 outbreak, Singapore has won praise for its ‘gold standard’ response. Still, Singaporean medical leaders caution that several critical issues must first be addressed to quell the ongoing epidemic.
Chinese Scientists Sequence Genome Of COVID-19
A research group in China has sequenced the genome of the COVID-19 virus and reported that the virus most likely originated from bats.
How Graphene Protects Copper From Corrosion
Scientists in South Korea have demonstrated that graphene forms a hybrid layer with copper oxide to slow down further corrosion of copper metal.
Advancing Antibody Research
Powerful antibody engineering technologies and a culture of collaboration set Chugai Pharmabody Research apart, says CEO Dr. Tomoyuki Igawa.